Abstract
Focal adhesions and actin cytoskeleton are involved in cell growth, shape and movement and in tumor invasion. Mitogen-induced changes in actin cytoskeleton are accompanied by changes in the tyrosine phosphorylation of several focal adhesion proteins. In this study, we have investigated the role of RAFTK, a cytoplasmic tyrosine kinase related to focal adhesion kinase (FAK), in heregulin-mediated signal transduction in breast cancer cells. Stimulation of T47D cells with heregulin (HRG) induced the tyrosine phosphorylation of RAFTK and the formation of a multiprotein complex. Analyses of the members of the HRG-stimulated complex revealed that RAFTK is associated with p190 RhoGAP (p190), RasGAP and ErbB-2, and plays an essential role in mediating the tyrosine phosphorylation of p190 by Src. Mutation of the Src binding site within RAFTK (402) abolished the phosphorylation of p190. In addition, upon HRG stimulation of T47D cells, association of ErbB-2 with RAFTK was observed and found to be indirect and mediated by Src. Expression of wild-type RAFTK (WT) significantly increased MDA-MB-435 and MCF-7 breast cancer cell invasion, while expression of the kinase-mutated RAFTK-R457 (KM) or the Src binding site mutant RAFTK (402) did not affect this cell invasion. Furthermore, HRG leads to the activation of MAP kinase which is mediated by RAFTK. These findings indicate that RAFTK serves as a mediator and an integration point between the GAP proteins and HRG-mediated signaling in breast cancer cells, and implicate RAFTK involvement in the MAP kinase pathway and in breast cancer cell invasion.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Abbreviations
- aa:
-
amino acids
- FAK:
-
focal adhesion kinase
- GAP:
-
GTPase-activating protein
- GST:
-
glutathione S-transferase
- HRG:
-
heregulin
- IP:
-
immunoprecipitation
- RAFTK:
-
related adhesion focal tyrosine kinase
- WB:
-
Western blot
References
Adam L, Crepin M, Lelong J-C, Spanakis E and Israel L . 1994 Int J Cancer 59: 262–268
Adam L, Vadlamudi R, Kondapaka SB, Chernoff J, Mendelsohn J and Kumar R . 1998 J Biol Chem 273: 28238–28246
Astier A, Avraham H, Manie SN, Groopman J, Canty T, Avraham S and Freedman AS . 1997a J Biol Chem 272: 228–232
Astier A, Manie SN, Avraham H, Hirai H, Law SF, Zhang Y, Golemis EA, Fu Y, Druker BJ, Haghayeghi N, Freedman AS and Avraham S . 1997b J Biol Chem 272: 19719–19724
Avraham S, London R, Fu Y, Ota S, Hiregowdara D, Li J, Jiang S, Pasztor LM, White RA, Groopman JE and Avraham H . 1995 J Biol Chem 270: 27742–27751
Bandyopadhyay D, Mandal M, Adam L, Mendelsohn J and Kumar R . 1998 J Biol Chem 273: 1568–1573
Beerli RR, Graus-Porta D, Woods-Cook K, Chen X, Yarden Y and Hynes NE . 1995 Mol Cell Biol 15: 6496–6505
Ben-Levy R, Paterson HF, Marshall CJ and Yarden Y . 1994 EMBO J 13: 3302–3311
Ben-Levy R, Peles E, Goldman-Michael R and Yarden Y . 1992 J Biol Chem 267: 17304–17313
Chang JH, Gill S, Settleman J and Parsons SJ . 1995 J Cell Biol 130: 355–368
Chen HC and Guan JL . 1996 Eur J Biochem 235: 495–500
Cheng JC, Frackelton Jr AR, Bearer EL, Kumar PS, Kannan B, Santos-Moore A, Rifai A, Settleman J and Clark JW . 1995 Cell Growth Differ 6: 139–148
Cohen BD, Green JM, Foy L and Fell HP . 1996 J Biol Chem 271: 4813–4818
Dikic I, Toldwa G, Lev S, Courtneidge SA and Schlessinger J . 1996 Nature 383: 547–550
Ellis C, Moran M, McCormick F and Pawson T . 1990 Nature 343: 377–381
Hall A . 1998 Science 279: 509–514
Hildebrand JD, Taylor JM and Parsons JT . 1996 Mol Cell Biol 16: 3169–3178
Hiregowdara D, Avraham H, Fu Y, London R and Avraham S . 1997 J Biol Chem 272: 10804–10810
Holmes WE, Sliwkowski MX, Akita RW, Henzel WJ, Lee J, Park JW, Yansura D, Abadi N, Raab H, Lewis GD, Shepard HM, Kuang WJ, Wood WI, Goeddel DV and Vandlen RL . 1992 Science 256: 1205–1210
Hu KQ and Settleman J . 1997 EMBO J 16: 473–483
Jockusch BM, Bubeck P, Giehl K, Kroemker M, Moschner J, Rothkegel M, Rudiger M, Schluter K, Stanke G and Winkler J . 1995 Annu Rev Cell Dev Biol 11: 379–416
Kaplan DR, Morrison DK, Wong G, McCormick F and Williams LT . 1990 Cell 61: 125–133
Karunagaran D, Tzahar E, Beerli RR, Chen X, Graus-Porta D, Ratzkin BJ, Seger R, Hynes NE and Yarden Y . 1996 EMBO J 15: 254–264
Keely PJ, Westwick JK, Whitehead IP, Der CJ and Parise LV . 1997 Nature 390: 632–636
Kumar R, Mandal M, Ratzkin BJ, Liu N and Lipton A . 1996 J Cell Biochem 62: 102–112
Lev S, Moreno H, Martinez R, Canoll P, Peles E, Musacchio JM, Plowman GD, Rudy B and Schlessinger J . 1995 Nature 376: 737–745
Li J, Avraham H, Rogers RA, Raja S and Avraham S . 1996 Blood 88: 417–428
Li R, Zhang B and Zheng Y . 1997 J Biol Chem 272: 32830–32835
Machesky LM and Hall A . 1996 Trends Cell Biol 6: 304–310
McGlade J, Brunkhorst B, Anderson D, Mbamalu G, Settleman J, Dedhar S, Rozakis-Adcock M, Chen LB and Pawson T . 1993 EMBO J 12: 3073–3081
McWhirter JR and Wang JY . 1991 Mol Cell Biol 11: 1553–1565
Nakahara H, Mueller SC, Nomizu M, Yamada Y, Yeh Y and Chen WT . 1998 J Biol Chem 273: 9–12
Nobes CD and Hall A . 1999 J Cell Biol 144: 1235–1244
Nobes CD, Hawkins P, Stephens L and Hall A . 1995 J Cell Sci 108: 225–233
Ohba T, Ishino M, Aoto H and Sasaki T . 1998 Biochem J 330: 1249–1254
Ojaniemi M and Vuori K . 1997 J Biol Chem 272: 25993–25998
Reedijk M, Liu XQ and Pawson T . 1990 Mol Cell Biol 10: 5601–5608
Ridley AJ and Hall A . 1992 Cell 70: 389–399
Ridley AJ, Paterson HF, Johnston CL, Diekmann D and Hall A . 1992 Cell 70: 401–410
Ridley AJ, Self AJ, Kasmi F, Paterson HF, Hall A, Marshall CJ and Ellis C . 1993 EMBO J 12: 5151–5160
Rozengurt E and Rodriguez-Fernandez JL . 1997 Essays Biochem 32: 73–86
Salgia R, Avraham S, Pisick E, Li J-L, Raja S, Greenfield EA, Sattler M, Avraham H and Griffin JD . 1996 J Biol Chem 271: 31222–31226
Sasaki H, Nagura K, Ishino M, Tobioka H, Kotani K and Sasaki T . 1995 J Biol Chem 270: 21206–21219
Sepp-Lorenzino L, Eberhard I, Ma Z, Cho C, Serve H, Liu F, Rosen N and Lupu R . 1996 Oncogene 12: 1679–1687
Serpente N, Birling MC and Price J . 1996 Mol Cell Neurosci 7: 391–403
Settleman J, Albright CF, Foster LC and Weinberg RA . 1992a Nature 359: 153–154
Settleman J, Narasimhan V, Foster LC and Weinberg RA . 1992b Cell 69: 539–549
Shaw LM, Rabinovitz I, Wang HF, Toker A and Mercurio AM . 1997 Cell 91: 949–960
Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A and Press MF . 1989 Science 244: 707–712
Taylor JM, Hildebrand JD, Mack CP, Cox ME and Parsons JT . 1998 J Biol Chem 273: 8063–8070
Acknowledgements
We thank Roanna London and Shuxian Jiang for their advice and technical help. We also thank Janet Delahanty for editing, Nancy DesRosiers for preparation of the figures, and Peter Park for typing of this manuscript. This work was supported in part by National Institutes of Health Grants HL55445, HL51456, DAMD 17-98-1-8032, DAMD 17-99-1-9078, and CA76226. This paper is dedicated to Charlene Engelhard and Ronald Ansin for their continuing friendship and support for our research program.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Zrihan-Licht, S., Fu, Y., Settleman, J. et al. RAFTK/Pyk2 tyrosine kinase mediates the association of p190 RhoGAP with RasGAP and is involved in breast cancer cell invasion. Oncogene 19, 1318–1328 (2000). https://doi.org/10.1038/sj.onc.1203422
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1203422
Keywords
This article is cited by
-
Galectin-3 promotes secretion of proteases that decrease epithelium integrity in human colon cancer cells
Cell Death & Disease (2023)
-
DUSP5P1 promotes gastric cancer metastasis and platinum drug resistance
Oncogenesis (2022)
-
p190A RhoGAP induces CDH1 expression and cooperates with E-cadherin to activate LATS kinases and suppress tumor cell growth
Oncogene (2020)
-
TGF-β stimulates Pyk2 expression as part of an epithelial-mesenchymal transition program required for metastatic outgrowth of breast cancer
Oncogene (2013)
-
PYK-2 is Tyrosine Phosphorylated after Activation of Pituitary Adenylate Cyclase Activating Polypeptide Receptors in Lung Cancer Cells
Journal of Molecular Neuroscience (2012)